Clinical significance of novel serum markers for the diagnosis, staging, and the prediction of prognosis in patients with renal cell carcinoma

Clinical significance of novel serum markers for the diagnosis, staging, and the prediction of prognosis in patients with renal cell carcinoma - Clinical significance of novel serum markers in renal cell carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002286

Enrollment

500

Registered

2009-08-15

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who will undergo the operation of renal cell carcinoma and the patients who were followed after the operation of renal cell carcinoma

Exclusion criteria

Exclusion criteria: The patients who did not agree with the purpose of this study

Design outcomes

Primary

Measure	Time frame
To evaluate the association between serum markers and 1)presence or absence of renal cell carcinoma, 2)cinical staging, 3)pathological staging (TNM clasification), 4) prognosis	—

Countries

Japan

Contacts

Public ContactRyuichi Mizuno

Keio University School of Medicine Department of Urology

moya3563@yahoo.co.jp0333531211

Outcome results